<DOC>
	<DOCNO>NCT01251133</DOCNO>
	<brief_summary>This multi-center , comparative , two-arm , parallel-group , single-blind , phase III study ass immunogenicity safety 4th LBVH0101 ( Haemophilus influenzae type b tetanus toxoid conjugate vaccine ) vaccination compare 4th Hiberix™ vaccination vaccination primary one healthy toddler complete primary vaccination LBVH0101 Hiberix™ LG-VHCL002 study .</brief_summary>
	<brief_title>Immunogenicity Safety Study 4th LBVH0101 After Primary Vaccination LG-VHCL002 Study</brief_title>
	<detailed_description>Primary objective : This study purpose compare assess immunogenicity 4th LBVH0101 Hiberix™ vaccination toddler complete primary vaccination LBVH0101 Hiberix™ , respectively , LG-VHCL002 study . Secondary objective : This study purpose compare assess safety 4th LBVH0101 Hiberix™ vaccination toddler complete primary vaccination LBVH0101 Hiberix™ LG-VHCL002 study . It also purpose assess persistence immunogenicity prior 4th vaccination toddler complete primary vaccination LBVH0101 Hiberix™ , respectively , LG-VHCL002 study .</detailed_description>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Were vaccinate LBVH0101 Hiberix™ three time LGVHCL002 study Healthy male female infant age 12 15 month birth The infant parents/legally acceptable representative could comply schedule visit study The parents/legally acceptable representative sign write consent form . Subject vaccinate 4th shot Haemophilus influenzae type b Subject schedule administered vaccine specify protocol allow accord Standard Immunization Schedule , 4th vaccination Completion Visit Subject suffer infectious disease cause Haemophilus influenzae type b Subject fever ≥ 37.5°C ( axillary temperature ) day vaccination There clear suspect immune function disorder Systemic corticosteroid ( prednisolone equivalent &gt; 0.5 mg/kg/day ) administer 14 day within 30 day prior administration test vaccine systemic immunosuppressant use</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>15 Months</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Communicable Diseases</keyword>
	<keyword>Infection</keyword>
	<keyword>Influenza</keyword>
	<keyword>Orthomyxoviridae Infections</keyword>
	<keyword>RNA Virus Infections</keyword>
	<keyword>Virus Diseases</keyword>
	<keyword>Respiratory Tract Infections</keyword>
	<keyword>Respiratory Tract Diseases</keyword>
</DOC>